Valuation: Abbott Laboratories

Market Cap 183B 159B 148B 136B 257B 17,433B 261B 1,750B 685B 8,694B 687B 672B 28,675B P/E 2026 *
30.3x
P/E 2027 * 23.4x
Enterprise Value 207B 180B 168B 154B 291B 19,737B 296B 1,981B 776B 9,842B 778B 761B 32,464B EV / Sales 2026 *
4.12x
EV / Sales 2027 * 3.74x
Free-Float
86.16%
Yield 2026 *
2.44%
Yield 2027 * 2.59%
1 week+1.43%
1 month+15.76%
3 months+18.97%
6 months-0.01%
Current year-12.82%
1 week 89.66
Extreme 89.66
96.5
1 month 77.08
Extreme 77.08
96.5
3 years 69.64
Extreme 69.64
134.1
5 years 69.64
Extreme 69.64
134.1
10 years 34
Extreme 34.003
134.1
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Change 5-day change 1-year change 3-year change Capi.($)
+1.17%+1.43%-18.04%-8.97% 183B
+1.42%+2.40%-3.79%+2.07% 109B
-0.38%+0.25%+6.23%+63.01% 60.57B
+2.37%+2.85%+44.34%+56.22% 51.8B
+2.34%+6.02%-5.82%-37.30% 45.64B
+3.74%+2.77% - - 33.22B
+4.09%+18.03%+13.57%-29.06% 31.49B
+2.06%+4.95%+45.83%-5.97% 24B
+1.76%+6.10%+1.44%+2.76% 22.26B
-0.54%+6.79%-9.83%+2.17% 21.51B
Average +1.68%+5.05%+8.21%+4.99% 44.42B
Weighted average by Cap. +1.53%+3.95%+0.08%+4.84%

Financials

2026 *2027 *
Net sales 50.3B 43.72B 40.82B 37.47B 70.65B 4,795B 71.88B 481B 188B 2,391B 189B 185B 7,887B 54.65B 47.5B 44.34B 40.71B 76.76B 5,209B 78.09B 523B 205B 2,598B 205B 201B 8,568B
Net income 6.25B 5.44B 5.08B 4.66B 8.79B 596B 8.94B 59.84B 23.44B 297B 23.49B 22.97B 981B 7.92B 6.89B 6.43B 5.9B 11.13B 755B 11.32B 75.81B 29.69B 377B 29.76B 29.1B 1,242B
Net Debt 24.17B 21B 19.61B 18B 33.94B 2,303B 34.53B 231B 90.55B 1,149B 90.77B 88.76B 3,789B 21.42B 18.61B 17.38B 15.95B 30.08B 2,041B 30.6B 205B 80.25B 1,018B 80.44B 78.66B 3,358B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
-
Date Price Change
26-08-03 92.84 +0.98%
26-07-31 €91.94 +0.59%
26-07-30 €91.40 -3.14%
26-07-29 €94.36 +0.21%
26-07-28 €94.16 +2.24%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
105.70USD
Average target price
118.42USD
Spread / Average Target
+12.03%

Quarterly revenue - Rate of surprise